Tobira Therapeutics (TBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TBRA | AZN | AMGN | GILD | VRTX |
| Company | Tobira Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 41.83 | 184.28 | 354.69 | 125.25 | 482.50 |
| High | 42.33 | 189.57 | 362.27 | 128.70 | 503.89 |
| Low | 40.39 | 184.28 | 354.16 | 125.00 | 482.20 |
| Latest | 42.09 | 188.41 | 358.33 | 127.88 | 491.34 |
| Change | +0.27 | +2.73 | +5.51 | +4.04 | +11.16 |
| % Change | +0.65% | +1.47% | +1.56% | +3.26% | +2.32% |
| Volume | 521,800 | 3,235,300 | 3,610,500 | 19,908,500 | 8,693,000 |
| 20-Day Average Volume | 230,795 | 2,033,530 | 3,214,730 | 9,948,485 | 1,819,235 |
| Previous Close | 41.82 | 185.68 | 352.82 | 123.84 | 480.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 40.68 | 180.76 | 344.84 | 126.73 | 451.93 |
| 20-Day Raw Stochastic | 91.81% | 92.71% | 90.14% | 41.05% | 85.04% |
| 20-Day Relative Strength | 87.55 | 54.84 | 58.70 | 48.02 | 67.80 |
| Weighted Alpha | +35.00 | +27.54 | +26.61 | +10.50 | +17.51 |
| Today's Opinion | N/A | 16% Sell | 56% Buy | 56% Sell | 40% Buy |
| Previous Opinion | N/A | 24% Sell | 56% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | N/A | 8% Sell | 8% Sell | 8% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.42% since 10/24/16 | +7.71% since 06/18/26 | +6.14% since 06/18/26 | +3.33% since 06/18/26 | +8.79% since 06/18/26 |
| Low | 40.39 on 10/31/16 | 175.11 on 06/22/26 | 337.60 on 06/22/26 | 123.00 on 06/22/26 | 453.21 on 06/22/26 |
| High | 42.33 on 10/31/16 | 189.57 on 06/26/26 | 362.27 on 06/26/26 | 128.70 on 06/26/26 | 503.89 on 06/26/26 |
| 1-Month | |||||
| %Chg | +5.91% since 09/30/16 | +0.65% since 05/26/26 | +6.66% since 05/26/26 | -4.37% since 05/26/26 | +12.71% since 05/26/26 |
| Low | 39.40 on 10/04/16 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 42.33 on 10/31/16 | 189.57 on 06/26/26 | 362.27 on 06/26/26 | 137.20 on 05/29/26 | 503.89 on 06/26/26 |
| 3-Month | |||||
| %Chg | +876.57% since 07/29/16 | +2.73% since 03/26/26 | +1.46% since 03/26/26 | -6.58% since 03/26/26 | +8.29% since 03/26/26 |
| Low | 3.76 on 08/02/16 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 42.33 on 10/31/16 | 207.30 on 04/10/26 | 362.27 on 06/26/26 | 142.97 on 04/09/26 | 503.89 on 06/26/26 |
| 6-Month | |||||
| %Chg | +434.82% since 04/29/16 | +1.40% since 12/26/25 | +7.63% since 12/26/25 | +2.55% since 12/26/25 | +6.14% since 12/26/25 |
| Low | 3.76 on 08/02/16 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 42.33 on 10/31/16 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 787,090 | 292,206,592 | 193,393,568 | 158,771,968 | 124,704,544 |
| Shares Outstanding, K | 18,820 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -49,620,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 1,060,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -13,340,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | -2.81 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 11/08/16 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.05 | 15.96 | 14.80 | 28.55 |